The Scientists and Researchers at Verge Genomics leverage advanced computational biology, drug discovery, and disease modeling techniques to identify and validate new targets for neurodegenerative disease treatments. They employ a multidisciplinary approach, integrating molecular biology, pharmacology, and bioinformatics to accelerate the development and optimization of life-saving therapeutics.